⌘K

Login Start Free

Home/Filings/4/0001235645-06-000001

4//SEC Filing

MUELLER ALAN L 4

Accession 0001235645-06-000001

CIK 0000890465other

View on SEC.gov Company Profile

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 7:08 PM ET

Size

7.7 KB

Accession

0001235645-06-000001

Insider Transaction Report

Form 4

Period: 2006-01-17

NPS PHARMACEUTICALS INCNPSP

VP, Drug Discovery

Transactions

Award
Stock Option
2006-01-17+8,875→ 8,875 total
Exercise: $14.96From: 2007-01-17Exp: 2016-01-17→ Common Stock (8,875 underlying)
Award
Stock Option
2006-01-17+438→ 438 total(indirect: By Spouse)
Exercise: $14.96From: 2007-01-17Exp: 2016-01-17→ Common Stock (438 underlying)

Footnotes (1)

[F1]Stock option granted under the 1998 Stock Option Plan. The option becomes exercisable based on the following four-year vesting schedule: 28% on the first anniversary of the grant, and 2% each month thereafter.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

NPS PHARMACEUTICALS INC

CIK 0000890465

Entity typeother

Related Parties

1

filerCIK 0001235645

Filing Metadata

Form type: 4
Filed: Jan 18, 7:00 PM ET
Accepted: Jan 19, 7:08 PM ET
Size: 7.7 KB

View on SEC.gov